ArticleScientific reports2026
Design, synthesis and biological evaluation of novel chalcone-derived thioxopyridine and pyrazolopyridine compounds as antimicrobial agents.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
- Retracted
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The present work deals with the synthesis of some new chalcone, 2- thioxopyridine,2-methylthiopyridine, 2-hydrazinopyridine and 3-amino-1H-pyrazolo[3,4-b]pyridine derivatives containing biologically active substituents. The starting material of the present study was synthesis of the 2-cyanoethanethioamide from malononitrile using a modified Brunskill procedure, followed by the synthesis of the 1,3-diarylprop-2-en-1-one (chalcone) from a ketone and an aldehyde. 2-Thioxopyridines were obtained through Michael addition of α,β-unsaturated ketones with 2-cyanothioacetamide to afford the non-isolable intermediates 8 & 9 followed by cyclization and subsequent dehydration and dehydrogenation of the cyclized product to give compound 4-(furan-2-yl)-6-(4- methoxyphenyl)-2-thioxo-1,2-dihydropyridine-3-carbonitrile which was reacted with methyl iodide in methanolic sodium methoxide to afford the corresponding 4-(furan-2-yl)-6-(4-methoxyphenyl)-2-(methylthio) pyridine-3-carbonitrile, which was reacted with hydrazine hydrate to give the corresponding 2-hydrazinopyridines, which cyclized to afford the corresponding 3-aminopyrazolo[3,4-b]pyridine derivatives and were characterized by FT-IR,
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.